Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints Rob Gallo as head of corporate communications, Europe and Canada

Will lead efforts to combine communications efforts in two regions

Rob Gallo - TakedaJapan-based Takeda Pharmaceuticals has promoted its interim head of corporate communications for Europe Rob Gallo to a permanent role that also covers Canada.

Gallo had been in his interim position since 2010, overseeing Europe-wide media campaigns, and will now be based at Takeda's regional headquarters in Zurich, Switzerland.

His new responsibilities will include unifying local communication teams as Takeda prepares to combine its Canadian and European businesses into a single Takeda subsidiary, ensuring communication aligns to the company's new strategic model as well as preparing teams for the launch of several products.

Gallo said: “I am delighted to be joining Takeda permanently to help deliver corporate objectives in what is a very exciting stage of the company's development.”

Before joining Takeda, Gallo was a director of Operandi Partners, a corporate communications and issues management consultancy based in London. 

In addition to his pharmaceutical experience, he has also held senior communications posts across a range of FMCG companies in the UK, Italy and Australia.

13th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HealthCircle Communications

Hello. We’re HealthCircle - a multi-channel healthcare communications agency with offices in London, New York and Singapore who offer a...

Latest intelligence

Shining our spotlight on… the patient
The second issue of our new SPOTLIGHT ON series is live! In this issue, we discuss the role of patient insights and what impact it has on improving patient outcomes...
Healthcare in the Digital Age
Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship....
Opinion piece: Patient-centricity and pharma – where are we now?
Patient-centricity is a term that has gained currency in the pharma industry in recent years, and most major companies in the sector are now dedicating resources to ensure that they...

Infographics